Klank, S.; van Stein, C.; Grüneberg, M.; Ottolenghi, C.; Rauwolf, K.K.; Grebe, J.; Reunert, J.; Harms, E.; Marquardt, T.
Enteric-Coated Cysteamine Bitartrate in Cystinosis Patients. Pharmaceutics 2023, 15, 1851.
https://doi.org/10.3390/pharmaceutics15071851
AMA Style
Klank S, van Stein C, Grüneberg M, Ottolenghi C, Rauwolf KK, Grebe J, Reunert J, Harms E, Marquardt T.
Enteric-Coated Cysteamine Bitartrate in Cystinosis Patients. Pharmaceutics. 2023; 15(7):1851.
https://doi.org/10.3390/pharmaceutics15071851
Chicago/Turabian Style
Klank, Sabrina, Christina van Stein, Marianne Grüneberg, Chris Ottolenghi, Kerstin K. Rauwolf, Jürgen Grebe, Janine Reunert, Erik Harms, and Thorsten Marquardt.
2023. "Enteric-Coated Cysteamine Bitartrate in Cystinosis Patients" Pharmaceutics 15, no. 7: 1851.
https://doi.org/10.3390/pharmaceutics15071851
APA Style
Klank, S., van Stein, C., Grüneberg, M., Ottolenghi, C., Rauwolf, K. K., Grebe, J., Reunert, J., Harms, E., & Marquardt, T.
(2023). Enteric-Coated Cysteamine Bitartrate in Cystinosis Patients. Pharmaceutics, 15(7), 1851.
https://doi.org/10.3390/pharmaceutics15071851